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Abstract
Introduction
Cigarette smoking is a well-established risk factor for the development and progression of
coronary artery disease (CAD) and it is strongly related to cardiac morbidity and mortality.
Therefore, this study aimed to compare the angiographic profile and immediate clinical
outcomes in young male smokers and non-smokers without any other cardiac risk factors
presented with ST-elevation myocardial infarction (STEMI).
Methods
This study includes young (≤40 years) male patients presented without cardiac risk factors other
than smoking. Angiographic profile and immediate outcome of primary percutaneous coronary
intervention (PCI) were collected from the hospital database.
Results
A total of 580 young male patients were included in this study, 51.2% (297) were smokers.
Baseline characteristics and presentation were similar for smoker and non-smoker groups.
Angiographic profile was not significantly different for smokers in terms of pre-procedure
thrombolysis in myocardial infarction (TIMI) flow (p = 0.373), the number of vessels involved (p
= 0.813), infarct-related artery (p = 0.834), and left ventricular dysfunction (p = 0.311). Similarly,
in-hospital outcomes of primary PCI were not significantly different in smokers. Post-
procedure no-reflow was in 3.4% vs. 2.8%; p = 0.708, acute stent thrombosis in 1.7% vs. 0.4%; p
= 0.114 and in-hospital mortality in 1.0% vs. 1.4%; p = 0.657 of the smoker and non-smoker
group, respectively.
Conclusion
Our study concludes smoking has no significant impact on the angiographic profile and
immediate clinical outcomes of primary PCI after STEMI in young males, without any other
conventional cardiac risk factors. With these findings, further multicenter prospective studies
are needed to identify other potential causes in such patients.
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Introduction
Asians are more than half of the world population and more than a quarter of the population of
the developing world live in South Asian countries, namely, Pakistan, Bangladesh, India, Sri
Lanka, Nepal, and Bhutan [1,2]. South Asian populations are known to have a higher tendency
of coronary artery disease (CAD) and possess different genetic profiles and lifestyle than the
western population [2]. Effective preventive measures for CAD in this population is crucial to
curtailing the global disease burden. Identification and management of risk factors for CADs
such as hypertension, hypercholesterolemia, diabetes, and smoking have proved to be effective
preventive strategies in the western population [3]. In the last two decades, a transformation in
dietary habits and lifestyle has been witnessed for the south Asian population due to
urbanization and globalization of dietary behavior [3-6]. Such rapid transformation has led to
an escalation of CAD in the region.
According to the World Health Organization (WHO), global annual deaths attributable to
cardiovascular diseases (CVD) are around 17.9 million, and more than 75% of these cases are
from developing countries [7]. CADs are considered to be the disease of old age, unfortunately,
the incidence of CAD is increased among the younger population [8,9]. A local study reported
cigarette smoking as the second most prevalent CVD risk factor, after increased BMI, among
young (<45 years) patients [10]. A paradoxical phenomenon of favorable outcomes after acute
myocardial infarction (AMI) was observed for smokers. In later studies, this phenomenon was
attributed to the young age and lesser severe disease among smokers [11,12]. Smokers were
found to develop ST-elevation myocardial infarction (STEMI) about 10 years earlier than non-
smokers and smokers have higher sex- and age-adjusted one-year mortality [13].
Cigarette smoking is a well-established risk factor for the development and progression of
coronary heart disease and is strongly related to morbidity and mortality and is a leading risk
factor of CAD in our young population [10,13]. Data are scarce for the Pakistani population;
therefore, this study aimed to compare the angiographic profile and immediate clinical
outcomes in young male smokers and non-smokers without any other cardiac risk factor
presented with STEMI and who underwent coronary intervention at a cardiac center in Karachi,
Pakistan.
Materials And Methods
This retrospective observational study was conducted at the National Institute of
Cardiovascular Diseases (NICVD) Karachi, Pakistan. The ethical review committee of the
institute approved the study (ERC-33/2018) and in accordance with the Declaration of Helsinki,
written informed consent was obtained from all patients regarding the procedure as well as the
use of data for research purposes. Data for the study were extracted from the institutional
primary percutaneous coronary intervention (PCI) database for the period from September 2015
to August 2018. As an institutional practice, demographics, presentation, diagnostic tests, and
outcomes data were collected on pre-defined proforma, after patients consent, and anonymized
data were available after institutional approval. In this study, we included young (<= 40 years)
male patients who presented with STEMI and who undergone primary PCI. Patients with
comorbid known risk factors of CAD, other than smoking, such as hypertension (HTN), diabetes
mellitus (DM), family history of CAD, and dyslipidemia were excluded from the study. The
patient selection criteria for the study were presented in Figure 1.
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FIGURE 1: Patients selection criteria for the study
PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction
The STEMI was defined and managed as per the ACCF/AHA STEMI diagnosis and management
guidelines. As a routine assessment, angiography and primary PCI procedures were performed
and interpreted by consultant cardiologists with the experience of five years or more. After
routine workup, electrocardiographic (ECG) and cardiac enzyme assessment, clinical
presentation (KILLIP class), symptom onset to hospital arrival time, and door to balloon time
were recorded. Patients history regarding known risk factors was obtained such as HTN (at least
six months history of any antihypertensive medication), DM (at least six months history of any
antihyperglycemic medication or insulin or glycated hemoglobin (HbA1c) > 6.5%), dyslipidemia
(low-density lipoprotein cholesterol (LDL-C) levels > 130 mg/dL and/or high-density
lipoprotein cholesterol (HDL-C) levels < 40 mg/dL), and family history (patient positive history
of premature ischemic heart disease (IHD) in first degree relatives, male less than 55 years of
age or female less than 65 years of age). Patients with a history of currently smoking five
cigarettes a day for at least one year or equivalent were classified as smokers.
The angiographic profile of the patients was assessed in terms of chronic total occlusion (CTO),
defined as thrombolysis in myocardial infarction (TIMI) flow grade 0, the number of diseased
vessels, infarct-related (culprit) artery, lesion complexity, involvement of side branch, left
ventricular (LV) dysfunction, and thrombus grading. Intra and post-procedure, in-hospital,
outcomes include procedure success (TIMI flow grade III), peri-procedural use of intra-aortic
balloon pump (IABP) and export catheter, no-reflow (TIMI flow grade 0-I), acute stent
thrombosis, and all-cause in-hospital mortality.
Patients were divided into two groups, smokers and non-smokers. Demographic profile,
angiographic profile and immediate outcomes of primary PCI were compared in two groups.
Statistical analyses of the extracted data were performed using IBM SPSS Statistics for
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Windows, Version 21.0 (IBM Corp., Armonk, NY). Mean (± standard deviation) and percentage
(frequency) were computed appropriately and the Mann-Whitney U test, for continuous
variables, and chi-square test, for categorical variables, were performed. P ≤ 0.05 was taken as
the level of significance.
Results
A total of 580 young male patients were included in this study, 51.2% (297) were smokers.
Smoker and non-smoker groups were similar in terms of age (35.29 ± 4.59 years vs. 35.54 ± 4.49
years, p = 0.575), symptom onset to hospital arrival time (238.87 ± 230.00 minutes vs. 239.19 ±
187.83 minutes, p = 0.145), and door to balloon time (80.35 ± 49.30 minutes vs. 83.78 ± 71.6
minutes, p = 0.622). Comparison of baseline characteristics of smokers and non-smokers are
presented in Table 1.
Characteristics Total Smokers Non-smokers p-value
Total 580 297 (51.2%) 283 (48.8%) -
Age (years) 35.41 ± 4.54 35.29 ± 4.59 35.54 ± 4.49 0.575
Body Mass Index (kg/m2) 25.79 ± 3.13 25.88 ± 3.58 25.71 ± 2.56 0.78
KILLIP class
I 533 (91.9%) 272 (91.6%) 261 (92.2%)
0.612
II 24 (4.1%) 15 (5.1%) 9 (3.2%)
III 11 (1.9%) 5 (1.7%) 6 (2.1%)
IV 12 (2.1%) 5 (1.7%) 7 (2.5%)
Symptom onset to hospital arrival time
Mean ± SD minutes 239.18 ± 210.3 238.87 ± 230 239.5 ± 187.83 0.145
≤ 120 minutes 202 (34.8%) 110 (37%) 92 (32.5%)
0.253
> 120 minutes 378 (65.2%) 187 (63%) 191 (67.5%)
Door to balloon time
Mean ± SD minutes 82.02 ± 61.18 80.35 ± 49.3 83.78 ± 71.6 0.622
≤ 90 minutes 429 (74%) 221 (74.4%) 208 (73.5%)
0.802
> 90 minutes 151 (26%) 76 (25.6%) 75 (26.5%)
TABLE 1: Comparison of baseline characteristics of smokers and non-smokers
Angiographic profile was not significantly different for smokers in terms of pre-procedural TIMI
flow (p = 0.373), number of vessels involved (p = 0.813), infarct-related artery (p =0.834), and LV
dysfunction (p = 0.311). A comparison of the angiographic profile of smokers and non-smokers
are presented in Table 2.
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Characteristics Total Smokers Non-smokers p-value
Total 580 297 (51.2%) 283 (48.8%) -
Chronic total occlusion 287 (50.7%) 156 (54%) 131 (47.3%) 0.078
Number of vessels involved
None 1 (0.2%) 1 (0.3%) 0 (0%)
0.813
Single vessel (SVD) 406 (70%) 206 (69.4%) 200 (70.7%)
Two vessels (2VD) 119 (20.5%) 61 (20.5%) 58 (20.5%)
Three vessels (3VD) 48 (8.3%) 25 (8.4%) 23 (8.1%)
Left Main (LM) 6 (1%) 4 (1.3%) 2 (0.7%)
Infarct related artery
None 1 (0.2%) 1 (0.3%) 0 (0%)
0.834
Left anterior descending (LAD) 411 (70.9%) 211 (71%) 200 (70.7%)
Right coronary (RCA) 104 (17.9%) 56 (18.9%) 48 (17%)
Left circumflex (LCX) 52 (9%) 23 (7.7%) 29 (10.2%)
Ramus 3 (0.5%) 1 (0.3%) 2 (0.7%)
Left main (LM) 4 (0.7%) 2 (0.7%) 2 (0.7%)
Diagonal 5 (0.9%) 3 (1%) 2 (0.7%)
Lesion complexity
None 4 (0.7%) 1 (0.3%) 3 (1.1%)
0.595
A 18 (3.1%) 12 (4%) 6 (2.1%)
B 116 (20%) 59 (19.9%) 57 (20.1%)
C 356 (61.4%) 178 (59.9%) 178 (62.9%)
High C 51 (8.8%) 29 (9.8%) 22 (7.8%)
Non high C 35 (6%) 18 (6.1%) 17 (6%)
Side branch involvement 68 (11.7%) 40 (13.5%) 28 (9.9%) 0.181
Left ventricular dysfunction 328 (56.6%) 174 (58.6%) 154 (54.4%) 0.311
Thrombus grading
No 43 (7.4%) 18 (6.1%) 25 (8.8%)
0.209
Possible 42 (7.2%) 19 (6.4%) 23 (8.1%)
Small 61 (10.5%) 37 (12.5%) 24 (8.5%)
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Moderate 109 (18.8%) 52 (17.5%) 57 (20.1%)
Large 85 (14.7%) 39 (13.1%) 46 (16.3%)
Total 240 (41.4%) 132 (44.4%) 108 (38.2%)
TABLE 2: Comparison of the angiographic profile of smokers and non-smokers
Similarly, immediate clinical outcomes of primary PCI were not significantly different in
smokers. Post-procedure no-reflow was observed in 3.4% (10) vs. 2.8% (eight); p = 0.708, acute
stent thrombosis in 1.7% (five) vs. 0.4% (one); p = 0.114 and in-hospital mortality in 1.0%
(three) vs. 1.4% (four); p = 0.657 of the smoker and non-smoker group, respectively.
Discussion
The CAD in the young patient has altogether different manifestations due to the differences in
clinical outcomes, presentation, and risk profile. CAD is no longer remains the old age disease,
it is becoming more prevalent among the young population due to increased risk profile such as
smoking, diabetes, and sedentary lifestyles [8,14]. In clinical practice, premature STEMI
comprises of 2%-12% of the total STEMI [8,14,15].
Among the other potential risk factors, such as unhealthy eating habits, obesity, and lack of
physical activeness, smoking is the most prevalent risk factor [13]. A study conducted in our
local population by Nadeem et al. [10] reported 46% current smokers among young (<45 years)
patients with a history of IHD. Various other studies in the past reported smoking as high as
more than 80% in patients with premature myocardial infarction (MI) [16,17]. In our study, we
found 51.2% smokers among young (≤ 40 years) male patients presented with STEMI having no
other cardiac risk factors such as diabetes, hypertension, dyslipidemia, and obesity.
Nicotine, carbon monoxide, and oxidant gases are the three basic constituents through which
smoking deteriorates the cardiovascular system. The sympathomimetic effects of nicotine
induce coronary artery vasoconstriction, leads to an increase in blood pressure, heart rate, and
myocardial contractility [14,18]. Due to comparative more avid binding of carbon monoxide
with hemoglobin, as compared to oxygen, it reduces the transportation of oxygen in the blood
resulting in scarcity of oxygen within the heart [14,19,20]. Finally, the oxidant gases induce
inflammation, cause endothelial damage, and increase plasma fibrinogen resulting in enhance
coagulability. It also contributes to the thrombogenesis and platelet activation via oxidizing the
LDL particles [19-21].
The smoker’s paradox, an observational paradoxical phenomenon of favorable outcomes after
AMI in smokers, is a common observation of various studies; however, there exists a
controversy regarding smoker’s paradox in young patients. Chen et al. concluded evidence to
support the existence of a smoker’s paradox in young (≤ 45 years) patients, while, Liu et al.
reported no paradoxical phenomenon in outcomes of AMI in young smokers [9, 22]. It is
important to address this phenomenon because it not only a clinical decision dilemma for
clinicians, but also it is misleading for smoker patients [22]. In our study, we observed no
significant differences in in-hospital outcomes of smokers and non-smokers patients, with no
other conventional cardiac risk factor, suggesting no evidence of smoker’s paradox in our
young population.
To the best of our knowledge, this is the first study comparing the angiographic profile of young
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smokers and non-smokers, without any conventional cardiac risk factors, in our population. We
found that male smokers and non-smokers had a similar clinical and angiographic profile in
terms of KILLIP class at presentation, symptom onset to hospital arrival time, the extent of
CAD, culprit vessel, lesion complexity, left ventricular function, and thrombus grading.
Similarly, in-hospital outcomes such as post-procedure no-reflow, acute stent thrombosis, and
mortality were similar for smoker and non-smoker sub-groups. Our study findings are aligned
with the finding of a systematic review and meta-analysis conducted by Liu et al. [9]. But
persistent smoking after revascularization is an independent predictor of long-term
reoccurrence of major adverse cardiac events (MACE) [13,14]. Therefore, emphasis on smoking
cessation has a pivotal role in reducing the risk of MACE after AMI. In literature, the rate of
smoking cessation after AMI varies from 28% to 77% depending on the definition of quitting
and smoking [23-25]. In-hospital, as well as post-discharge smoking cessation counseling and
programs should be part of every cardiac rehabilitation program. As quitting smoking is a
complex and difficult process; therefore, effective interventions, both pharmacological and
psychological, are the need of the time.
Our study has several limitations, the study was a retrospective study; therefore, the impact of
quantum of smoking (number of packs or sticks) and the duration of smoking on outcomes
could not be assessed. Secondly, due to the small sample size and single-center coverage, the
finding of insignificant differences among smokers and non-smokers needs further
confirmation in multicenter prospective studies with a larger sample size.
Conclusions
Our study concludes smoking has no significant impact on the angiographic profile and
immediate clinical outcomes of primary PCI after STEMI in young males, without any other
conventional cardiac risk factors. With these findings, further multicenter prospective studies
are needed to identify other potential causes in such patients.
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